{"disease":{"id":"safety-and-tolerability-in-healthy-subjects","name":"safety and tolerability in healthy subjects"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03239379","title":"A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Bioniz Therapeutics","has_results":false},{"nct_id":"NCT07153900","title":"BACK4 Safety Evaluation","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"SWIMS America Corp.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}